Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Revelation Biosciences, Inc. - Warrant
No Price
01.05.2026 19:00
Current Prices from Revelation Biosciences, Inc. - Warrant
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
REVBW
USD
01.05.2026 19:00
0,008 USD
-0,00010 USD
-1,25 %
IEX
REVBW
USD
30.04.2026 13:42
0,008 USD
-
Share Float & Liquidity
Free Float66,65 %
Shares Float3,95 M
Shares Outstanding5,92 M
Company Profile for Revelation Biosciences, Inc. - Warrant Share
Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company's lead therapeutic candidate is REVTx-99, an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses, such as SARS-CoV-2 comprising its variants, influenza A and B, parainfluenza, rhinovirus, and RSV, as well as is being developed for other indications comprising allergic rhinitis and chronic nasal congestion. It also develops REVTx-200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for immunity; and REVDx-501, a rapid home use diagnostic to detect respiratory viral infection. The company was founded in 2019 and is based in New York, New York.
